Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,795 | -18,794 | -13,711 | -5,023 | -874 |
| Depreciation Amortization | 230 | 778 | 557 | 352 | 165 |
| Accounts payable and accrued liabilities | 149 | -1,213 | -669 | -161 | -579 |
| Other Working Capital | -2,495 | 71 | 142 | 1,587 | 347 |
| Other Operating Activity | 92 | -12,261 | -10,853 | -11,905 | -7,112 |
| Operating Cash Flow | $-10,819 | $-31,419 | $-24,534 | $-15,150 | $-8,053 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 19 | -1,297 | -1,021 | -806 | -171 |
| Investing Cash Flow | $19 | $-1,297 | $-1,021 | $-806 | $-171 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,910 | 19,910 | 19,910 | 19,910 |
| Common Stock Issued | N/A | 64 | 28 | 28 | 6 |
| Financing Cash Flow | $N/A | $19,974 | $19,938 | $19,938 | $19,916 |
| Beginning Cash Position | 70,324 | 83,066 | 83,066 | 83,066 | 83,066 |
| End Cash Position | 59,524 | 70,324 | 77,449 | 87,048 | 94,758 |
| Net Cash Flow | $-10,800 | $-12,742 | $-5,617 | $3,982 | $11,692 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,819 | -31,419 | -24,534 | -15,150 | -8,053 |
| Capital Expenditure | -138 | -1,297 | -1,021 | -806 | -171 |
| Free Cash Flow | -10,957 | -32,716 | -25,555 | -15,956 | -8,224 |